InteliGel™ from Green Evolution Technologies
USA Manufacturing • Majority American Farmer Funded • American Farmers First
Green Evolution Technologies is raising capital via Regulation Crowdfunding (Reg CF) to scale its patented InteliGel™ technology, already backed by $15M+ in purchase orders and up to 65% savings on inputs like irrigation water and fertilizers. Substantially reduces soil erosion and nitrates from leaching into water supply, puts carbon back in the ground, while delivering crop yield increases.
Tell us you’re interested in our upcoming Reg CF offering. Non-binding — no money is being accepted at this stage.
This page is a “testing the waters” communication under Regulation Crowdfunding. It is NOT an offer to sell securities. No money or other consideration is being solicited, and if sent, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until the offering statement (Form C) is filed and only through DealMaker Securities LLC. An indication of interest involves no obligation or commitment of any kind.
Global farming is trapped in a cycle of expensive inputs, drought or wasted water & fertilizer, toxic runoff, and degrading soil. The market is desperate for a real solution.
70% of global freshwater goes to farming. Half is wasted through inefficient irrigation and evaporation. Drought persists in the majority of US Farm Land today.
~65% of fertilizer never reaches crops. Billions wasted annually while toxic nitrates leach into ecosystems and poison drinking water supplies.
24 billion tons of fertile soil lost every year, threatening the global food supply for future generations.
Global food demand is projected to grow 60% by 2050, while seed, fertilizer, and water costs squeeze farm margins.
Our patented Hydrogel Development Process (HDP) produces InteliGel™ that absorbs up to 3,000× its weight in water and liquids, significantly more than known competing hydrogels based on internal benchmarking. Low cost. Biocompatible. Biodegradable. Non-toxic. Validated in independent third-party trials.
From competitive grant wins to multi-million dollar purchase orders, GET has the receipts.
Won top award at the START, GROW & STAY Conference, hosted by Accelerate California & the Fresno WET Center. Competed against hundreds of applicants. Judged on:
$75,000 grant to design a custom InteliGel™ solution for almond and tree growers in the Central Valley.
Water, Energy & Technology Center
Accelerate CaliforniaColorado-based Godsey Precision Ag found GET’s corn testing results online and reached out directly:
A Nebraska-based, Precision Planting dealer found GET’s 2025 Precision Planting corn testing results online and scheduled an intro discovery call:
50+ producers requested to purchase and trial InteliGel™ for Spring 2026. GET wasn’t planning on going to market until 2027. Precision Planting’s published 2024 and 2025 test results drove interest from many dealers and customer farmers. Many wanted thousands of pounds to trial in Spring 2026.
Independent trial results across crops and climates. We lead with bushels gained and net return per acre. The only numbers farmers and investors trust.
Academic evaluation at Brookings & Beresford, SD. InteliGel™-treated rows with reduced fertilizer rates vs. untreated control at normal fertilizer rates. Numeric gains overall, with some Brookings treatment combinations trending higher with InteliGel™.
Side-by-side comparison at Precision Planting’s Precision Technology Institute in Pontiac, IL. InteliGel™-treated rows vs. untreated control. Positive in both seasons: +19.2 Bu/A and +$59.09/A in 2024 (25 lb/A) and +8.9 Bu/A and +$25.21/A in 2025 (15 lb/A).
Side-by-side comparison at Indian Head Farms, Barron, WI. InteliGel™-treated rows vs. untreated control under identical conditions.
Side-by-side comparison at Spitak Region Farms, Lori Maz, Armenia. InteliGel™-treated rows with Van mineral mixture at varying rates vs. untreated control under identical conditions, except zero fertilizers applied at planting.
*Top 5 rank based only on PTI 2025 testing & trials.
Schedule your intro Zoom call to see the full 2024 and newly published 2025 Precision Planting PTI testing results. Independent, third-party validation that speaks for itself.
Register Interest & Get Early Access →Single facility projected to generate $300M annual revenue at ~$100M EBITDA (33% net margin) at full ramp. U.S. expansion plan calls for 20 facilities across key agricultural zones. 200M acres is the U.S. total addressable market (TAM), counting only core commodity row crops. This does not include specialty crops, indoor controlled environment, tree farms, golf courses or turf, vineyards, and direct to consumer for home gardening, flower beds and house plants use.
Per-facility revenue, EBITDA, and facility count are forward-looking projections based on management assumptions. They are not guarantees of future performance. Actual results may differ materially. See risk factors and disclosures below.
Forward-looking projections based on contracted demand, the facility buildout schedule, and modeled financial results for growers. Actual results may differ materially. See disclosures below.
Forward-Looking Statements: The financial projections above are forward-looking statements based on management assumptions and models. They involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially. These projections are not guarantees of future performance and should not be relied upon as such. Actual results may vary significantly.
Perfect timing meets proven technology in a rapidly expanding market.
The global hydrogel market is projected to reach $80B by 2035, growing at double-digit rates. First movers win.
Targeted $300M revenue per facility at ~33% net margins at full ramp, recurring sales model, USDA non-toxic eligibility, and legislative tailwinds. Forward-looking projection.
Patented HDP process creates significant barriers to entry and sustainable competitive advantage.
$15M+ in purchase orders, Fresno State grant win, field-tested technology with documented results and growing adoption.
Addresses universal agricultural challenges across all climate zones and crop types. No geographic limits.
Backed by the originators of Hydrogel Development Process Theory. Scientists with 55+ years of Nobel Prize-level R&D, 350+ peer-reviewed publications, 10 years of industrialization, and decades of large-scale industrial polymer science.
65+ years total of Nobel Prize–level R&D crystallized into a proprietary manufacturing process built around defensible IP and trade secrets.
Green Evolution Technologies owns the North American Patent rights filed with the USPTO and holds first right of refusal on all International patent rights on the Hydrogel Development Process (HDP) process.
GET’s planned facility buildout calls for $18M for the first half of a production facility ($30M fully built out), compared with industry estimates of $300M+ for conventional hydrogel plants. Patented HDP is designed to eliminate the need for massive chemical reactors and batch processing.
Proprietary formulations for crop-specific InteliGel™ blends developed over decades of research. GET exclusively licensed the know-how and use of the large-scale industrial machinery our industrializers invented.
300 years of combined leadership experience in agribusiness, polymer sciences, and commercialization.
GET co-founder revolutionizing agriculture and reshaping the future of food security and sustainable farming. Dedicated to harnessing breakthrough science and transformative technologies.
GET co-founder with a life dedicated to harnessing breakthrough science and transformative technologies. Founder of Bangdasarov Crystal Group and AgroforLife.
Inventor and holder of multiple patents ranging from robotics to physical chemistry. Founder of Bangdasarov Crystal Group and AgroforLife.
Soil scientist, precision ag expert, and cropping systems specialist focusing on no-till farming, crop efficiency, and technology adoption. Founded Godsey Precision Ag.
New market and business channel development, sales leader, and capital formation expert. Founder of Sun Operative, a solar customer acquisition platform.
A growth-focused executive with over a decade of entrepreneurial and startup experience, specializing in building and scaling businesses through high-impact sales and marketing strategies.
Investing in early-stage private companies involves substantial risk. The following material risks could adversely affect your investment. This is not an exhaustive list. Please review the full offering documents before investing.
GET’s production process has been validated at pilot scale. Scaling to full commercial production involves engineering, supply chain, and operational variables that may increase costs, delay timelines, or require additional capital beyond current projections.
While GET holds USA and international patents with additional applications pending, the agricultural technology space is competitive. Third parties may challenge the validity of GET’s patents or assert competing claims, resulting in costly litigation and potential disruption to commercialization.
GET’s commercial success is linked to the agricultural sector, which is subject to weather events, crop price volatility, government farm policy changes, and shifts in grower adoption rates. These macro factors are outside the company’s control and may affect revenue timing and growth.
GET’s operations and proprietary formulation knowledge are substantially dependent on a small core leadership team. The loss of one or more key personnel, including scientific, operational, or commercial leadership, could materially disrupt execution and investor returns.
Important: Green Evolution Technologies intends to conduct an offering under Regulation Crowdfunding (Reg CF) via DealMaker Securities LLC, a FINRA-registered funding portal. This page is a testing-the-waters communication only — no securities are being offered or sold at this time, and no money is being accepted. Past performance of field trials does not guarantee future commercial results. Any future investment will involve a high degree of risk, including the possible loss of your entire investment.
Important information about investing in Regulation Crowdfunding offerings. Please read carefully before investing.
Regulation CF allows investors to invest in startups and early-growth companies. This is different from helping a company raise money on Kickstarter; with Regulation CF Offerings, you aren’t buying products or merchandise — you are buying a piece of a company and helping it grow.
Accredited investors can invest as much as they want. But if you are NOT an accredited investor, your investment limit depends on either your annual income or net worth, whichever is greater. If the number is less than $124,000, you can only invest 5% of it. If both are greater than $124,000 then your investment limit is 10%.
To calculate your net worth, just add up all of your assets and subtract all of your liabilities (excluding the value of the person’s primary residence). The resulting sum is your net worth.
We cannot give tax advice, and we encourage you to talk with your accountant or tax advisor before making an investment.
Individuals over 18 years of age can invest.
There will always be some risk involved when investing in a startup or small business. And the earlier you get in the more risk that is usually present. If a young company goes out of business, your ownership interest could lose all value. You may have limited voting power to direct the company due to dilution over time. You may also have to wait about five to seven years (if ever) for an exit via acquisition, IPO, etc. Because early-stage companies are still in the process of perfecting their products, services, and business model, nothing is guaranteed. That’s why startups should only be part of a more balanced, overall investment portfolio.
The [security type] (the “Shares”) of Green Evolution Technologies (the “Company”) are not publicly-traded. As a result, the shares cannot be easily traded or sold. As an investor in a private company, you typically look to receive a return on your investment under the following scenarios: The Company gets acquired by another company. The Company goes public (makes an initial public offering). In those instances, you receive your pro-rata share of the distributions that occur, in the case of acquisition, or you can sell your shares on an exchange. These are both considered long-term exits, taking approximately 5–10 years (and often longer) to see the possibility for an exit. It can sometimes take years to build companies. Sometimes there will not be any return, as a result of business failure.
Shares sold via Regulation Crowdfunding offerings have a one-year lockup period before those shares can be sold under certain conditions. The exceptions are sales:
(i) to the Company;
(ii) to an “accredited investor” within the meaning of Rule 501 of Regulation D under the Securities Act;
(iii) as part of an offering registered under the Securities Act with the SEC; or
(iv) to a member of the Investor’s family or the equivalent, to a trust controlled by the Investor, to a trust created for the benefit of a member of the family of the Investor or equivalent, or in connection with the death or divorce of the Investor or other similar circumstance.
If a company does not reach their minimum funding target, all funds will be returned to the investors after the close of the offering.
All available disclosure information can be found on the landing pages for our Regulation Crowdfunding offering.
You can cancel your investment at any time, for any reason, until 48 hours prior to a closing occurring. If you’ve already funded your investment and your funds are in escrow, your funds will be promptly refunded to you upon cancellation. To process your refund, see the instructions here.
At a minimum, the company will be filing with the SEC and posting on its website an annual report, along with certified financial statements. Those should be available 120 days after the fiscal year end. If the company meets a reporting exception, or eventually has to file more reported information to the SEC, the reporting described above may end. If these reports end, you may not continually have current financial information about the company.
DealMaker Securities is acting as the regulated funding portal (intermediary) for this specific offering. Once this offering closes, there is no guarantee that DealMaker Securities or its affiliates will maintain any formal relationship or continue providing services to the company, although they may choose to work together on future offerings.
Funding History
Seed Round · December 2023
GET raised $1.34M USD, oversubscribed for the $1M USD Seed Round by way of SAFE Note Agreements at a $10M USD Valuation Cap.
Seed Plus Round · April 2026
GET raised $2.55M USD, oversubscribed for the $2M USD Seed Plus Round by way of SAFE Note Agreements at a Post-Money $50M USD Valuation Cap.
The Company intends to raise capital under Regulation Crowdfunding (Reg CF) via DealMaker Securities LLC. Register your interest now to be notified when the offering opens.
Register Interest →Expected valuation caps, round structure, and other terms shown on this page are preliminary and subject to change. No securities are being offered or sold at this time; no money is being accepted. Any offer will be made only through the Company’s Form C filed with the SEC.